Literature DB >> 8006689

Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated.

E Kahana1, N Zilber, J H Abramson, V Biton, Y Leibowitz, O Abramsky.   

Abstract

The incidence and prevalence of multiple sclerosis (MS) were compared, controlling for age, in native-born Israelis of different origins and in immigrants to Israel. This comparison was carried out in two populations, countrywide and in Jerusalem. In the countrywide population, ascertainment was based mainly on hospitalizations; it included 252 patients who were native-born and 150 who had immigrated from Africa-Asia (AA immigrants). The 89 MS patients of Jerusalem also included patients diagnosed in outpatient clinics. In native-born Israelis whose father was born in Europe-America (I-EA), the incidence and prevalence of MS were found to be as high as or even higher than that found previously in immigrants from Europe-America. Among native-born Israelis whose father was born in Africa or Asia (I-AA), the yearly age-adjusted incidence and prevalence rates were found to be 1.4- to 1.8-fold higher than among AA immigrants, pointing to environmental factors. The incidence and prevalence rates in the I-EA were 1.2- to 1.6-fold higher than in the I-AA, pointing to genetic factors. These results seem to point to both environmental and genetic factors in the aetiology of MS. Further research is needed, however, to disentangle the genetic factors from possible environmental differences in the two ethnic groups.

Entities:  

Mesh:

Year:  1994        PMID: 8006689     DOI: 10.1007/BF00868444

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

1.  Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies.

Authors:  M Elian; S Nightingale; G Dean
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

2.  Appparent familial multiple sclerosis in three generations. Report of a family with histocompatibility antigen typing.

Authors:  T D Bird
Journal:  Arch Neurol       Date:  1975-06

3.  Multiple sclerosis in immigrant and native populations of Israel.

Authors:  U Leibowitz; E Kahana; M Alter
Journal:  Lancet       Date:  1969-12-20       Impact factor: 79.321

4.  Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS.

Authors:  J F Kurtzke; K Hyllested
Journal:  Neurology       Date:  1986-03       Impact factor: 9.910

Review 5.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

6.  HLA and heterogeneity of multiple sclerosis.

Authors:  T Engell; N E Raun; M Thomsen; P Platz
Journal:  Neurology       Date:  1982-09       Impact factor: 9.910

7.  Estimation of a common effect parameter from sparse follow-up data.

Authors:  S Greenland; J M Robins
Journal:  Biometrics       Date:  1985-03       Impact factor: 2.571

Review 8.  Epidemiologic contributions to multiple sclerosis: an overview.

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1980-07       Impact factor: 9.910

9.  Possible risk factors in multiple sclerosis as found in a national twin study.

Authors:  R D Currier; R Eldridge
Journal:  Arch Neurol       Date:  1982-03

10.  Segregation and linkage analysis of 40 multiplex multiple sclerosis families.

Authors:  R W Haile; L Iselius; S E Hodge; N E Morton; R Detels
Journal:  Hum Hered       Date:  1981       Impact factor: 0.444

View more
  8 in total

Review 1.  The genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

Review 2.  Genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

3.  Multiple sclerosis in Jordan: A clinical and epidemiological study.

Authors:  Khalid El-Salem; Ehsan Al-Shimmery; Khalid Horany; Ali Al-Refai; Kefah Al-Hayk; Yousef Khader
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

4.  Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway.

Authors:  Catherine Smestad; Leiv Sandvik; Trygve Holmoy; Hanne Flinstad Harbo; Elisabeth Gulawson Celius
Journal:  J Neurol       Date:  2007-12-20       Impact factor: 4.849

Review 5.  The Role of Exposomes in the Pathophysiology of Autoimmune Diseases I: Toxic Chemicals and Food.

Authors:  Aristo Vojdani; Elroy Vojdani
Journal:  Pathophysiology       Date:  2021-12-18

6.  The causal cascade to multiple sclerosis: a model for MS pathogenesis.

Authors:  Douglas S Goodin
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

Review 7.  Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.

Authors:  Carole Lunny; Jennifer A Knopp-Sihota; Shawn N Fraser
Journal:  BMC Neurol       Date:  2013-05-06       Impact factor: 2.474

Review 8.  Metabolomics as a promising tool for improving understanding of multiple sclerosis: A review of recent advances.

Authors:  Zhicheng Liu; Jeffrey Waters; Bin Rui
Journal:  Biomed J       Date:  2022-01-15       Impact factor: 7.892

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.